Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
Développer la qualité dans le champ sanitaire, social et médico-social
Logo
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. CAPERGYL (dihydroergotoxine (mésilate de))
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • Établissements de santé
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

CAPERGYL (dihydroergotoxine (mésilate de))

Medicine - Posted on Nov 02 2011 - Updated on Jun 12 2019
Active substance (DCI)
  • dihydroergotoxine (mésilate de)
history (3)
  • 11/2/11

    CAPERGYL (dihydroergotoxine (mésilate de))

    CAPERGYL (dihydroergotoxine (mésilate de))
    icône flèche
  • 11/7/07

    CAPERGYL (dihydroergotoxine (mésilate de))

    CAPERGYL (dihydroergotoxine (mésilate de))
    icône flèche
  • 5/31/06

    CAPERGYL (dihydroergotoxine (mésilate de))

    CAPERGYL (dihydroergotoxine (mésilate de))
    icône flèche
Technical information
ATC code
  • C04AE01
Manufacturer
Laboratoire BAILLEUL-BIORGA
Presentation

CAPERGYL 4,5 mg DOSE QUOTIDIENNE UNIQUE, capsule Boîte de 30 capsules (CIP : 327 173-9)

All our publications
    Alzheimer’s disease and mental disorders Central nervous system diseases Drug therapy Geriatrics

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
eNrFmF1v2jAUhu/5FVHukxAohU2BamPthtRqjBZt2k1lkgOYGTv1B4X9+jmEaunkqK2pu0vi5D0nPsfPeUlytl0TbwNcYEb7fhw2fQ9oyjJMF31/enMR9PyzQSNZoQ2q3NYNm2Hc8r2UICH6frEazgBREf64uvwE+nng/qDhJWy2glQ+uk9JTMIvSCyvUF7c4yUbhjNvDXLJsr6fK7m/6iVCcp3F4J7xXyJHKSTR4Up1dXV7Ur2eRIXYM1SVAH6J6MIoCtRKM1WcA5VDJGHB+M4oPU9vW73uabPZswqBxQQEUzyFMZLLMWcbnEFmjoSIAKsg8/vsGviGgCyCGMWjVboWVuJohbYTuBuZk/6gV4dyK4NmEHe7nfZJu9Vrtdtdq1C8slXm5tEvEeU5z25b73qdOG5FQKMU5cAXOxJkeLnLONM/mGRbTCFYg8BEVzfIwLJ6Y8YlIo7qhsXwcQc6isPh7sn+yLDICdqFK5HbbhXiSC8D15xw9yLFG9xwTa6irv/oU0VI9MKspweuOMq4wNaQKSpr8HIxsd2IIaMStvUVtSOi3B56EYN4PdnfjJqnwVjNCE5toaexpEDI6WRUz7y3xcVHJGDK3fHiO6YZuxevz6Fq3R1ln+9RahTVJYqLGp3GnY71Mfupm6xmSp0rznKINKGwOAY8IzpnxyJH961Z6qFr37Bh96aKpYhAja0KLPmkO/XBBTo7C+7OWblgFP18fmPbQN8U8N31/qdRGmf9aunt+O1iKOiOrc395f1fYuAZnvuk17bbBMXNlFlKmYv3UbREIhBIb1Q45/9hRlQGt7v/A07cQemWSs46Sn1WDtDn18/2ND7lHY71w4fnD77bGENyBUfUoQS3M7yOzl+f2H/NsLO0x4/w4i7M3rgiiRl1ZZfUzOyVjp0RurT0gms+fJ3Pcc1XmtrWTKLyC9GgkUTF16FB4w9fkx3R
KfzY2HYHVTcqEkLA